Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/24284
Title: A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Aged,Angiogenesis Inhibitors/adverse effects/pharmacokinetics/*therapeutic use,Anorexia/chemically induced,Area Under Curve,Carcinoma, Squamous Cell/*drug therapy/metabolism/pathology,Drug Administration Schedule,Fatigue/chemically induced,Female,Head and Neck Neoplasms/*drug therapy/metabolism/pathology,Humans,Hypoxia-Inducible Factor 1, alpha Subunit/metabolism,Immunohistochemistry,Indoles/blood/pharmacokinetics/*therapeutic use,Male,Metabolic Clearance Rate,Middle Aged,Neoplasm Metastasis,Neoplasm Recurrence, Local,Pyrroles/blood/pharmacokinetics/*therapeutic use,Survival Analysis,Thrombocytopenia/chemically induced,Treatment Outcome,Vascular Endothelial Growth Factor A/metabolism
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/24284
ISSN: 1432-0843
Link: http://www.ncbi.nlm.nih.gov/pubmed/19655144
http://www.springerlink.com/content/37426q115253870v/fulltext.pdf
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Fountzilas-2010-A phase II study of.pdf638.92 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons